Erytech sinks after Graspa miss in AML study

Erytech Pharma S.A. (Euronext:ERYP; NASDAQ:ERYP) lost $8.80 (31%) to $19.20 on NASDAQ Friday after it said

Read the full 161 word article

User Sign In